Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

US Patent 12404329 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
Detector with focally aligned pixels2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Heterodimeric proteins2025
Heterodimeric antibodies that bind CD3 and CLDN62025
Heterodimeric antibodies that bind CD3 and CLDN62025
Bispecific binding agents binding to CLDN18.2 and CD32025
Anti-CD28 x anti-PSMA antibodies2025
Anti-CD28 x anti-PSMA antibodies2025